398 related articles for article (PubMed ID: 29319180)
1. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
[TBL] [Abstract][Full Text] [Related]
2. The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes.
Hörbelt T; Tacke C; Markova M; Herzfeld de Wiza D; Van de Velde F; Bekaert M; Van Nieuwenhove Y; Hornemann S; Rödiger M; Seebeck N; Friedl E; Jonas W; Thoresen GH; Kuss O; Rosenthal A; Lange V; Pfeiffer AFH; Schürmann A; Lapauw B; Rudovich N; Pivovarova O; Ouwens DM
Diabetologia; 2018 Sep; 61(9):2054-2065. PubMed ID: 29754289
[TBL] [Abstract][Full Text] [Related]
3. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
4. WISP1 is a novel adipokine linked to inflammation in obesity.
Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
[TBL] [Abstract][Full Text] [Related]
5. Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation.
Pyun DH; Kim TJ; Park SY; Lee HJ; Abd El-Aty AM; Jeong JH; Jung TW
Mol Cell Endocrinol; 2021 Dec; 538():111464. PubMed ID: 34601002
[TBL] [Abstract][Full Text] [Related]
6. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle.
Jung TW; Chung YH; Kim HC; Abd El-Aty AM; Jeong JH
Mol Cell Endocrinol; 2018 Jul; 470():26-33. PubMed ID: 29111387
[TBL] [Abstract][Full Text] [Related]
7. The Effects of microRNA-515-5p on the Toll-Like Receptor 4 (TLR4)/JNK Signaling Pathway and WNT1-Inducible-Signaling Pathway Protein 1 (WISP-1) Expression in Rheumatoid Arthritis Fibroblast-Like Synovial (RAFLS) Cells Following Treatment with Receptor Activator of Nuclear Factor-kappa-B Ligand (RANKL).
Cai D; Hong S; Yang J; San P
Med Sci Monit; 2020 May; 26():e920611. PubMed ID: 32361708
[TBL] [Abstract][Full Text] [Related]
8. Mechanical ventilation enhances extrapulmonary sepsis-induced lung injury: role of WISP1-αvβ5 integrin pathway in TLR4-mediated inflammation and injury.
Ding X; Tong Y; Jin S; Chen Z; Li T; Billiar TR; Pitt BR; Li Q; Zhang LM
Crit Care; 2018 Nov; 22(1):302. PubMed ID: 30445996
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
[TBL] [Abstract][Full Text] [Related]
10. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK-PPARδ-dependent pathway in mice.
Jung TW; Hwang HJ; Hong HC; Yoo HJ; Baik SH; Choi KM
Diabetologia; 2015 Sep; 58(9):2096-105. PubMed ID: 26105792
[TBL] [Abstract][Full Text] [Related]
11. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
13. WISP1 mediates lung injury following hepatic ischemia reperfusion dependent on TLR4 in mice.
Tong Y; Yu Z; Zhang R; Ding X; Chen Z; Li Q
BMC Pulm Med; 2018 Dec; 18(1):189. PubMed ID: 30522479
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
[TBL] [Abstract][Full Text] [Related]
15. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
16. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
[TBL] [Abstract][Full Text] [Related]
18. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis.
Song CY; Zeng X; Wang Y; Shi J; Qian H; Zhang Y; Fang JQ; Sheng X; Zheng JM; Chen YX
J Gastroenterol Hepatol; 2015 Feb; 30(2):405-12. PubMed ID: 25089018
[TBL] [Abstract][Full Text] [Related]
19. JIP3 knockout protects mice against high fat diet-induced liver injury.
Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
[TBL] [Abstract][Full Text] [Related]
20. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
